Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Understanding Women’s Health Through the Lens of Hormonal Sensitivity: Genetics, Mechanisms and Health Trajectories

Project description

Mapping the hormone sensitivity spectrum in women

Hormonal sensitivity conditions, such as premenstrual syndrome, hormonal treatment side effects and menopause symptoms affect billions of women worldwide. These conditions reflect how differently individuals respond to natural fluctuations in oestrogen and progesterone. The ERC-funded UNDERwHER project aims to redefine the concept of the hormone sensitivity spectrum (HSS) by combining genetic data, health records and self-reported symptoms data from the Estonian Biobank. The goal is to identify distinct patterns of hormone sensitivity, uncover the genetic determinants and biological pathways behind them, and explore links to long-term health outcomes. The findings aim to advance our understanding of women’s hormonal health and enable more personalised and effective hormonal treatments.

Objective

Hormonal sensitivity conditions such as premenstrual syndrome, hormonal medication side effects, and (peri)menopausal symptoms affect billions of women but remain poorly understood. These conditions share a common factor: fluctuations in estrogen and progesterone levels that interact with endocrine, neurological, and metabolic systems, creating a continuum of individual hormone sensitivity. UNDERwHER aims to redefine the hormone sensitivity spectrum (HSS) by addressing its biological underpinnings and health impact.

UNDERwHER builds on the applicant's recent work on 42 female reproductive health phenotypes, which demonstrated the value of genetics in understanding women’s health. By leveraging the data and opportunities in Estonian Biobank (N=140K women), we will combine self-reported HSS phenotypes with longitudinal healthcare data and app-based menstrual tracking. This unparalleled dataset will be used to characterize HSS static and dynamic subtypes through advanced clustering and modeling. Genome-wide association studies and functional genomic tools will identify genetic variants and biological pathways underlying HSS, revealing shared genetic links with other health domains. To evaluate the wider health impact, we will map the associations between HSS and long-term health outcomes, and by integrating genetic risk with observational data we will inform personalized hormonal medication recommendations. Finally, genetics-informed cellular models will uncover the transcriptomic effects of hormonal fluctuations, providing mechanistic insights.

This research will help to i) provide a new concept on female hormonal health, ii) map the biological pathways linked to HSS to provide input for drug discovery, iii) propose evidence-based approaches for genetics-informed hormonal drug prescription, and iv) facilitate research on this topic by creating unique data resources and cellular models, with the ultimate goal of improving women's health and wellbeing.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-COG

See all projects funded under this call

Host institution

TARTU ULIKOOL
Net EU contribution
€ 1 863 125,00
Address
ULIKOOLI 18
51005 Tartu
Estonia
Region
Eesti Eesti Lõuna-Eesti
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 863 125,00

Beneficiaries (1)